Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

chronic diseases

6 posts
RRoche
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux
Read More

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux

  • 2026-04-29
Company Logo The Saudi Arabia in vitro diagnostics (IVD) market is set for steady growth, driven by the…
NNovartis
Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics
Read More

Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics

  • 2026-04-24
Company Logo The Germany Anemia Treatment Market is set to reach USD 1.05 billion by 2034, growing at…
NNovartis
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Read More

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

  • 2026-04-16
Novartis Pharma AG Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales…
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

  • 2026-03-23
Novartis Pharma AG New Rhapsido® REMIX-1 & -2 pooled analysis on symptom control as early as week 1…
RRoche
United States Home Healthcare Market Analysis Report 2025-2033 Featuring 3M Healthcare, Apple, Arkray, B. Braun Melsungen, BD And Co, F. Hoffmann-La Roche, Fresenius, and Hollister
Read More

United States Home Healthcare Market Analysis Report 2025-2033 Featuring 3M Healthcare, Apple, Arkray, B. Braun Melsungen, BD And Co, F. Hoffmann-La Roche, Fresenius, and Hollister

  • 2026-02-12
Company Logo The United States Home Healthcare Market is projected to grow significantly, from US$ 115.13 billion in…
RRoche
United States Home Healthcare Market Analysis Report 2025-2033 Featuring 3M Healthcare, Apple, Arkray, B. Braun Melsungen, BD And Co, F. Hoffmann-La Roche, Fresenius, and Hollister
Read More

United States Home Healthcare Market Analysis Report 2025-2033 Featuring 3M Healthcare, Apple, Arkray, B. Braun Melsungen, BD And Co, F. Hoffmann-La Roche, Fresenius, and Hollister

  • 2026-02-12
Company Logo The United States Home Healthcare Market is projected to grow significantly, from US$ 115.13 billion in…
Switzerland
www.europesays.com